Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Omeros
Biotech
FDA delays Omeros' 2nd attempt at transplant drug’s approval
After receiving more information from the biotech, the FDA informed the company that the decision date has been pushed back to Dec. 26.
James Waldron
Aug 15, 2025 5:55am
Omeros stock up after data analysis spurs BLA resubmission plan
Dec 19, 2024 10:54am
Omeros stops kidney disease phase 3 after interim review fail
Oct 16, 2023 8:45am
Omeros saddles up for 2nd charge at transplant drug approval
Mar 14, 2023 9:30am
Omeros' Hail Mary throw for blood clot med delayed at FDA
Aug 17, 2022 11:21am
FDA rejects Omeros drug over difficulties estimating its effect
Oct 18, 2021 8:15am